Resolute Science

📍 San Diego, United States🗓 Founded 2020👥 7 employees💰 Last funded 2025
Biotechnology Research🌐 resolutescience.com
Website LinkedIn
Resolute Science is a preclinical-stage biotechnology company developing a novel class of pan-cancer therapeutics for the treatment of aggressive and hard-to-treat solid tumors. By leveraging its proprietary MAC-TAC drug-delivery platform, Resolute is advancing a broad pipeline of first-in-class targeted cytotoxic payloads, radiopharmaceuticals, and imaging agents. Its lead asset, RS-5, is undergoing IND-enabling studies, with two additional preclinical programs underway. Resolute Sciences mission is to help people with cancer recover and return to their normal lives.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Resolute Science?
Resolute Science has 1 investors on record on gritt.io, 1 mid-stage.
When did Resolute Science last raise funding?
The most recent investment in Resolute Science recorded on gritt.io was in 2025.
When was Resolute Science founded?
Resolute Science was founded in 2020.
What industry is Resolute Science in?
Resolute Science operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Resolute Science based?
Resolute Science is headquartered in San Diego, United States.